STATEMENT OF CASH FLOWS - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ (60,700)	$ 7,178,411
Adjustments to reconcile net income (loss) to cash used in operating activities:
Change in fair value of derivative warrant liabilities		(8,648,000)
Income from investments held in Trust Account		(14,523)
Offering costs associated with derivative liabilities		743,650
Changes in operating assets and liabilities:
Prepaid expenses		(262,320)
Accounts payable	35,054	(110,085)
Accrued expenses	22,914	(38,558)
Franchise tax payable	2,643	197,356
Net cash used in operating activities	(89)	(876,953)
Cash Flows from Investing Activities
Cash deposited in Trust Account		(276,000,000)
Net cash used in investing activities		(276,000,000)
Cash Flows from Financing Activities:
Proceeds from note payable to related party		300,000
Repayment of note payable to related party	41,000	(41,000)
Proceeds received from initial public offering, gross		276,000,000
Proceeds received from private placement, net of note payable		7,520,000
Deferred offering costs paid	(64,850)
Proceeds from issuance of Class B common stock to Sponsor	25,000
Offering costs paid		(6,090,699)
Net cash provided by financing activities	1,150	277,688,301
Net increase in cash and cash equivalents	1,061	811,348
Cash and cash equivalents - beginning of the period		1,061
Cash and cash equivalents - end of the period	1,061	812,409
Supplemental disclosure of noncash activities:
Offering costs included in accounts payable		85,000
Reversal of accrued expenses		145,040
Deferred underwriting commissions in connection with the initial public offering		$ 9,660,000
Deferred offering costs included in accounts payable	160,759
Deferred offering costs included in accrued expenses	$ 145,040